Sympathetic function in human carriers of melanocortin-4 receptor gene mutations

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 4, 2010, Pages 1998-2002

  Sayk, Friedhelm ^a   Heutling, Dennis ^b   Dodt, Christoph ^a,c   Iwen, K Alexander ^a   Wellhoner, J Peter ^a   Scherag, Susann ^d   Hinney, Anke ^d   Hebebrand, Johannes ^d   Lehnert, Hendrik ^a,e  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c KLINIKUM BOGENHAUSEN   (Germany)

^d UNIVERSITY OF DUISBURG ESSEN   (Germany)

^e UNIVERSITY HOSPITAL COVENTRY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN; MELANOCORTIN 4 RECEPTOR;

ADOLESCENT; ADULT; ANTHROPOMETRY; APNEA; ARTICLE; BODY MASS; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR SYSTEM; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GENDER; GENE MUTATION; HEART RATE; HEMODYNAMICS; HETEROZYGOTE; HUMAN; MALE; OBESITY; PERONEUS NERVE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SUPINE POSITION; SYMPATHETIC FUNCTION; SYMPATHETIC NERVE; VASOCONSTRICTION; ADRENERGIC SYSTEM; BLOOD PRESSURE; GENETICS; INNERVATION; MIDDLE AGED; MUTATION; PATHOPHYSIOLOGY; PHYSIOLOGY; REGRESSION ANALYSIS; SKELETAL MUSCLE;

ADOLESCENT; ADULT; ANTHROPOMETRY; APNEA; BLOOD PRESSURE; CHILD; FEMALE; HEART RATE; HEMODYNAMICS; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MUTATION; OBESITY; RECEPTOR, MELANOCORTIN, TYPE 4; REGRESSION ANALYSIS; SYMPATHETIC NERVOUS SYSTEM; YOUNG ADULT;

EID: 77951648854     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-2297     Document Type: Article

References (20)

1. Matsumura K, Tsuchihashi T, Abe I, Iida M 2002 Central α-melanocyte-stimulating hormone acts at melanocortin-4 receptor to activate sympathetic nervous system in conscious rabbits. Brain Res 948:145-148
2. Greenfield JR, Miller JW, Keogh JM, Henning E, Satterwhite JH, Cameron GS, Astruc B, Mayer JP, Brage S, See TC, Lomas DJ, O'Rahilly S, Farooqi IS 2009 Modulation of blood pressure by central melanocortinergic pathways. N Engl J Med 360:44-52
3. Dunbar JC, Lu H 1999 Leptin-induced increase in sympathetic nervous and cardiovascular tone is mediated by proopiomelanocortin (POMC) products. Brain Res Bull 50:215-221
4. Kuo JJ, Silva AA, Hall JE 2003 Hypothalamic melanocortin receptors and chronic regulation of arterial pressure and renal function. Hypertension 41:768-774
5. Rahmouni K, Haynes WG, Morgan DA, Mark AL 2003 Role of melanocortin-4 receptors in mediating renal sympathoactivation to leptin and insulin. J Neurosci 23:5998-6004 (Pubitemid 36859438)
6. Scherrer U, Randin D, Tappy L, Vollenweider P, Jéquier E, Nicod P 1994 Body fat and sympathetic nerve activity in healthy subjects. Circulation 89:2634-2640
7. Davy KP, Orr JS 2009 Sympathetic nervous system behavior in human obesity. Neurosci Biobehav Rev 33:116-124
8. Straznicky NE, Eikelis N, Lambert EA, Esler MD 2008 Mediators of sympathetic activation in metabolic syndrome obesity. Curr Hypertens Rep 10:440-447
9. Dodt C, Lönnroth P, Wellhöner JP, Fehm HL, Elam M 2003 Sympathetic control of white adipose tissue in lean and obese humans. Acta Physiol Scand 177:351-357
10. Dodt C, Lönnroth P, Fehm HL, Elam M 2000 The subcutaneous lipolytic response to regional neural stimulation is reduced in obese women. Diabetes 49:1875-1879
11. Spraul M, Ravussin E, Fontvieille AM, Rising R, Larson DE, Anderson EA 1993 Reduced sympathetic nervous activity. A potential mechanism predisposing to body weight gain. J Clin Invest 92:1730-1735
12. Hinney A, Bettecken T, Tarnow P, Brumm H, Reichwald K, Lichtner P, Scherag A, Nguyen TT, Schlumberger P, Rief W, Vollmert C, Illig T, Wichmann HE, Schäfer H, Platzer M, Biebermann H, Meitinger T, Hebebrand J 2006 Prevalence, spectrum, and functional characterization of melanocortin-4 receptor gene mutations in a representative population-based sample and obese adults from Germany. J Clin Endocrinol Metab 91:1761-1769
13. Hinney A, Hohmann S, Geller F, Vogel C, Hess C, Wermter AK, Brokamp B, Goldschmidt H, Siegfried W, Remschmidt H, Schäfer H, Gudermann T, Hebebrand J 2003 Melanocortin-4 receptor gene: case-control study and transmission disequilibrium test confirm that functionally relevant mutations are compatible with a major gene effect for extreme obesity. J Clin Endocrinol Metab 88:4258-4267
14. Tank J, Heusser K, Diedrich A, Hering D, Luft FC, Busjahn A, Narkiewicz K, Jordan J 2008 Influences of gender on the interaction between sympathetic nerve traffic and central adiposity. J Clin Endocrinol Metab 93:4974-4978
15. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI 1997 Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 100:270-278 (Pubitemid 27349073)
16. Brito MN, Brito NA, Baro DJ, Song CK, Bartness TJ 2007 Differential activation of the sympathetic innervation of adipose tissues by melanocortin receptor stimulation. Endocrinology 148:5339-5347
17. Rahmouni K, Morgan DA, Morgan GM, Mark AL, Haynes WG 2005 Role of selective leptin resistance in diet-induced obesity hypertension. Diabetes 54:2012-2018
18. Tallam LS, Stec DE, Willis MA, da Silva AA, Hall JE 2005 Melanocortin-4 receptor-deficient mice are not hypertensive or salt-sensitive despite obesity, hyperinsulinemia, and hyperleptinemia. Hypertension 46:326-332
19. Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, O'Rahilly S 2003 Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 348:1085-1095 (Pubitemid 36337319)
20. Vaz M, Jennings G, Turner AG, Cox HS, Lambert G, Esler MD 1997 Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation 96:4323-4329